SREBP inhibits VEGF expression in human smooth muscle cells.

[1]  H. Sone,et al.  Lipid Synthetic Transcription Factor SREBP-1a Activates p21WAF1/CIP1, a Universal Cyclin-Dependent Kinase Inhibitor , 2005, Molecular and Cellular Biology.

[2]  Shwu‐Yuan Wu,et al.  SREBP-1c and Sp1 Interact to Regulate Transcription of the Gene for Phosphoenolpyruvate Carboxykinase (GTP) in the Liver* , 2004, Journal of Biological Chemistry.

[3]  A. Fukamizu,et al.  SREBPs suppress IRS-2-mediated insulin signalling in the liver , 2004, Nature Cell Biology.

[4]  O. Pachinger,et al.  Statins differentially regulate vascular endothelial growth factor synthesis in endothelial and vascular smooth muscle cells. , 2003, Atherosclerosis.

[5]  G. Vilahur,et al.  Modulation of ERG25 expression by LDL in vascular cells. , 2003, Cardiovascular research.

[6]  O. Pachinger,et al.  HMG-CoA Reductase Inhibitors Regulate Inflammatory Transcription Factors in Human Endothelial and Vascular Smooth Muscle Cells , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[7]  L. Badimón,et al.  Low-Density Lipoprotein Upregulates Low-Density Lipoprotein Receptor-Related Protein Expression in Vascular Smooth Muscle Cells: Possible Involvement of Sterol Regulatory Element Binding Protein-2-Dependent Mechanism , 2002, Circulation.

[8]  O. Pachinger,et al.  Atorvastatin decreases vascular endothelial growth factor in patients with coronary artery disease. , 2002, Journal of the American College of Cardiology.

[9]  M. Shibuya,et al.  Vascular Endothelial Growth Factor Is Necessary in the Development of Arteriosclerosis by Recruiting/Activating Monocytes in a Rat Model of Long-Term Inhibition of Nitric Oxide Synthesis , 2002, Circulation.

[10]  C. Heeschen,et al.  Statins Have Biphasic Effects on Angiogenesis , 2002, Circulation.

[11]  O. Pachinger,et al.  Vascular endothelial growth factor: angiogenesis, atherogenesis or both? , 2001, Journal of the American College of Cardiology.

[12]  J. Liao,et al.  Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[13]  H. Shimano.  Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. , 2001, Progress in lipid research.

[14]  M. Foretz,et al.  Sterol Regulatory Element-binding Protein-1c Mimics the Negative Effect of Insulin on Phosphoenolpyruvate Carboxykinase (GTP) Gene Transcription* , 2001, The Journal of Biological Chemistry.

[15]  M. Dake,et al.  Effect of human recombinant vascular endothelial growth factor165 on progression of atherosclerotic plaque. , 2001, Journal of the American College of Cardiology.

[16]  J. Abbruzzese,et al.  Constitutive Sp1 activity is essential for differential constitutive expression of vascular endothelial growth factor in human pancreatic adenocarcinoma. , 2001, Cancer research.

[17]  M. Dake,et al.  Vascular endothelial growth factor enhances atherosclerotic plaque progression , 2001, Nature Medicine.

[18]  L. Badimón,et al.  LDL Downregulates CYP51 in Porcine Vascular Endothelial Cells and in the Arterial Wall Through a Sterol Regulatory Element Binding Protein-2–Dependent Mechanism , 2001, Circulation research.

[19]  A. M. Lefer,et al.  Vascular effects of HMG CoA-reductase inhibitors (statins) unrelated to cholesterol lowering: new concepts for cardiovascular disease. , 2001, Cardiovascular research.

[20]  R. Nagai,et al.  Induction of VEGF gene transcription by IL-1 beta is mediated through stress-activated MAP kinases and Sp1 sites in cardiac myocytes. , 2000, Journal of molecular and cellular cardiology.

[21]  T. Osborne,et al.  Nutrient regulation of gene expression by the sterol regulatory element binding proteins: increased recruitment of gene-specific coregulatory factors and selective hyperacetylation of histone H3 in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[22]  C. Hsieh,et al.  Generation of a Dominant-negative Mutant of Endothelial PAS Domain Protein 1 by Deletion of a Potent C-terminal Transactivation Domain* , 1999, The Journal of Biological Chemistry.

[23]  R. Sato,et al.  Sterol Regulatory Element-binding Protein Negatively Regulates Microsomal Triglyceride Transfer Protein Gene Transcription* , 1999, The Journal of Biological Chemistry.

[24]  N. Tamura,et al.  Vascular endothelial growth factor (VEGF) expression in human coronary atherosclerotic lesions: possible pathophysiological significance of VEGF in progression of atherosclerosis. , 1998, Circulation.

[25]  P. Macfarlane,et al.  Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). , 1998, Circulation.

[26]  I. Shimomura,et al.  Cholesterol feeding reduces nuclear forms of sterol regulatory element binding proteins in hamster liver. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  A. Bist,et al.  Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  G. Siemeister,et al.  Sp1 recognition sites in the proximal promoter of the human vascular endothelial growth factor gene are essential for platelet-derived growth factor-induced gene expression , 1997, Oncogene.

[29]  S. Fukumoto,et al.  Protein Kinase C δ Inhibits the Proliferation of Vascular Smooth Muscle Cells by Suppressing G1 Cyclin Expression* , 1997, The Journal of Biological Chemistry.

[30]  J. Goldstein,et al.  The SREBP Pathway: Regulation of Cholesterol Metabolism by Proteolysis of a Membrane-Bound Transcription Factor , 1997, Cell.

[31]  R. Hammer,et al.  Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. , 1997, The Journal of clinical investigation.

[32]  S. McKnight,et al.  Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. , 1997, Genes & development.

[33]  P. Rigby,et al.  Trans-acting protein factors and the regulation of eukaryotic transcription: lessons from studies on DNA tumor viruses. , 1988, Genes & development.